A Randomised trial of anti-GM-CSF Otilimab in severe COVID-19 pneumonia (OSCAR)

By sjmartinez • October 14, 2022

Patel J, Bass D, Beishuizen A, Bocca Ruiz X, Boughanmi H, Cahn A, Colombo H, Criner GJ, Davy K, de-Miguel-Díez J, Doreski PA, Fernandes S, François B, Gupta A, Hanrott K, Hatlen T, Inman D, Isaacs JD, Jarvis E, Kostina N, Kropotina T, Lacherade JC, Lakshminarayanan D, Martinez-Ayala P, McEvoy C, Meziani F, Monchi M, Mukherjee S, Muñoz-Bermúdez R, Neisen J, O'Shea C, Plantefeve G, Schifano L, Schwab LE, Shahid Z, Shirano M, Smith JE, Sprinz E, Summers C, Terzi N, Tidswell MA, Trefilova Y, Williamson R, Wyncoll D, Layton M. A Randomised trial of anti-GM-CSF Otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2022 Oct 13:2101870. doi: 10.1183/13993003.01870-2021. Epub ahead of print. PMID: 36229048.

Tags: Harbor UCLA, Infectious Diseases, Publications

Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort

Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff[...]

A Fellow-Led Orientation to Mitigate Microaggressions in the Intensive Care Unit

Rink DE, Adamson R, Granados L, Cueva KL, Albert TJ. A Fellow-Led Orientation to Mitigate Microaggressions in the Intensive Care Unit. Med Educ. 2025 Aug[...]

Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence

Chan AA, Noguti J, Ramirez NM, Navarrete M, Lee DJ. Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence. J Invest Dermatol. 2025[...]